In Rohrbeck et al. (2008) dataset, increased ACAA2 correlated with the SCLC phenotype relative to lung adenocarcinoma as well as an increased expression of NE markers CHGA (P = 9.5*10-3) and CD56 (P = 3.81*10-2) (Supplementary Fig. S5A). The gene discussed is ACAA2; the disease is small cell lung carcinoma.